- Home
- OZK vs GRFS Comparison
OZK vs GRFS Comparison
Compare OZK & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OZK | GRFS |
|---|---|---|
| Founded | 1903 | 1940 |
| Country | United States | Spain |
| Employees | 3351 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.9B |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | OZK | GRFS |
|---|---|---|
| Price | $43.61 | $7.49 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $53.78 | $10.87 |
| AVG Volume (30 Days) | ★ 1.1M | 445.0K |
| Earning Date | 10-20-2026 | 07-28-2022 |
| Dividend Yield | ★ 4.31% | 1.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.19 | $1.73 |
| Revenue Next Year | $4.84 | $6.26 |
| P/E Ratio | ★ $8.01 | $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.37 | $6.96 |
| 52 Week High | $53.39 | $9.90 |
Technical Indicators
Market Signals| Indicator | OZK | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 23.46 | 49.92 |
| Support Level | $42.99 | $7.44 |
| Resistance Level | $49.42 | $8.36 |
| Average True Range (ATR) | 0.96 | 0.12 |
| MACD | -0.23 | 0.03 |
| Stochastic Oscillator | 5.60 | 81.93 |
Price Performance
Historical ComparisonAbout OZK Bank OZK
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides banking services, including checking, savings, money market, time deposits, and individual retirement accounts, as well as loan services, such as real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services, it also provides trust and wealth management, financial planning, online banking, and other related services.
About GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.